Organogenesis Holdings (ORGO) Treasury Shares (2019 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Treasury Shares of $5.6 million in Q1 2026, up 2.83% quarter-over-quarter from $5.5 million in Q4 2025, and up 17.69% on a YoY basis from $4.8 million in Q1 2025.
Organogenesis Holdings (ORGO) Treasury Shares (2019 - 2026) Analysis & Trends
Organogenesis Holdings' Treasury Shares history runs 8 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 17.69% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 17.69% YoY), while the FY2025 annual figure was $5.5 million, down 30.69% from the prior year.
- Treasury Shares was $5.6 million for Q1 2026 at Organogenesis Holdings, up from $5.5 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $7.9 million in Q4 2024 to a low of $198900.0 in Q3 2025.
- Historically, Treasury Shares has averaged $3.7 million across 5 years, with a median of $4.1 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 182.28% in 2023, then tumbled 95.37% in 2025.
- A 5-year view of Treasury Shares shows it stood at $1.4 million in 2022, then jumped by 182.18% to $3.9 million in 2023, then soared by 103.21% to $7.9 million in 2024, then slumped by 30.69% to $5.5 million in 2025, then rose by 2.83% to $5.6 million in 2026.
- The last three Treasury Shares figures came in at $5.6 million (Q1 2026), $5.5 million (Q4 2025), and $198900.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 107.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.80 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.42 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 17.13 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 7.24 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 19.58 Mn |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 5.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.65 Mn |
| Mar 31, 2026 | 5.65 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 198,900.00 |
| Sep 30, 2025 | 198,900.00 |
| Jun 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 4.79 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 7.92 Mn |
| Dec 31, 2024 | 7.92 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |